The potential of γδ CAR and TRuC T cells: An unearthed treasure
European Journal of Immunology · 2024-11 · 54 (11)
DOI: 10.1002/eji.202451074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 27.08.2024. Verfasst von Wolfgang W Schamel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Signaling Research Centres BIOSS and CIBSS; Department of Immunology, Faculty of Biology, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, gamma-delta, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, T-Lymphocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DFG under Germany's Excellence Strategy, Excellence Initiative of the German Federal and State Governments, Ministry for Science, Research and Arts of the State of Baden-Württemberg.
Abstract (Originalsprache)
Recent years have witnessed the success of αβ T cells engineered to express chimeric antigen receptors (CARs) in treating haematological cancers. CARs combine the tumour antigen binding capability of antibodies with the signalling functions of the T‐cell receptor (TCR) ζ chain and co‐stimulatory receptors. Despite the success, αβ CAR T cells face limitations. Possible solutions would be the use of γδ T cells and new chimeric receptors, such as TCR fusion constructs (TRuCs). Notably, γδ CAR T cells are gaining traction in pre‐clinical and clinical studies, demonstrating a promising safety profile in several pilot studies. This review delves into the current understanding of γδ CAR and TCR fusion construct T cells, exploring the opportunities and challenges they present for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Signaling Research Centres BIOSS and CIBSS; Department of Immunology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
- Department of Immunology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
- Centre for Chronic Immunodeficiency (CCI), Faculty of Medicine, University Clinics Freiburg, Freiburg, Germany.
- Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.
- Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, and Hamburg Centre for Translational Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
- Hamburg Centre for Translational Immunology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Trang Nguyen, Boris Fehse
Förderung
- DFG under Germany's Excellence Strategy
- Excellence Initiative of the German Federal and State Governments
- Ministry for Science, Research and Arts of the State of Baden-Württemberg
- German Research Foundation (DFG)
- FOR2799
- SFB1381
- SFB1479
- SFB1160
Zitieren
APA
Schamel, W. W., Zintchenko, M., Nguyen, T., Fehse, B., Briquez, P. S., & Minguet, S. (2024). The potential of γδ CAR and TRuC T cells: An unearthed treasure. European Journal of Immunology, 54(11). https://doi.org/10.1002/eji.202451074
Vancouver
Schamel WW, Zintchenko M, Nguyen T, Fehse B, Briquez PS, Minguet S. The potential of γδ CAR and TRuC T cells: An unearthed treasure. European Journal of Immunology. 2024;54(11). doi:10.1002/eji.202451074
BibTeX
@article{Schamel2024,
author = {Schamel, Wolfgang W and Zintchenko, Marina and Nguyen, Trang and Fehse, Boris and Briquez, Priscilla S and Minguet, Susana},
title = {The potential of γδ CAR and TRuC T cells: An unearthed treasure},
journal = {European Journal of Immunology},
year = {2024},
volume = {54},
number = {11},
doi = {10.1002/eji.202451074}
}
EUVIMED